TrianglePUBLICATIONS · 28291640
Pegylated interferon alfa-2a in patients with essential thrombocythaemia or polycythaemia vera: a post-hoc, median 83 month follow-up of an open-label, phase 2 trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Lancet Haematol
- Publication date
- 2017 Apr
- First author
- Masarova L
This record carries publication-notice metadata. Review the notices below before relying on it.
Publication notices
- absence is not clearance
- true
- has correction metadata
- true
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Lancet Haematol. 2017 Jun;4(6):e257. doi: 10.1016/S2352-3026(17)30085-6.
- note
- Source null
- related pmid
- 28583288
- relationship
- Erratum in
Authors and identifiers
- name
- Masarova L
- type
- Author
- name
- Patel KP
- type
- Author
- name
- Newberry KJ
- type
- Author
- name
- Cortes J
- type
- Author
- name
- Borthakur G
- type
- Author
- name
- Konopleva M
- type
- Author
- name
- Estrov Z
- type
- Author
- name
- Kantarjian H
- type
- Author
- name
- Verstovsek S
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Masarova L
- type
- Author
- name
- Patel KP
- type
- Author
- name
- Newberry KJ
- type
- Author
- name
- Cortes J
- type
- Author
- name
- Borthakur G
- type
- Author
- name
- Konopleva M
- type
- Author
- name
- Estrov Z
- type
- Author
- name
- Kantarjian H
- type
- Author
- name
- Verstovsek S
- type
- Author
- bibliography ids
- nci-bib-e25d6ec16b2ed2b22d969767
- book metadata
- content sha256
- 59fb0d7f7840f76e1cfbd08b1eae941f54395e58d6ae12b8424eab0c01db88be
- document type
- citation
- dois
- 10.1016/S2352-3026(17)30030-3
- electronic publication date
- display
- 2017 Mar 11
- precision
- day
- year
- 2017
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:28291640
- immutable id
- pubmed:28291640@59fb0d7f7840f76e1cfbd08b1eae941f54395e58d6ae12b8424eab0c01db88be
- journal
- abbreviation
- Lancet Haematol
- issn electronic
- 2352-3026
- issn print
- Source null
- issue
- 4
- name
- The Lancet. Haematology
- nlm unique id
- 101643584
- pages
- e165-e175
- volume
- 4
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- true
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Lancet Haematol. 2017 Jun;4(6):e257. doi: 10.1016/S2352-3026(17)30085-6.
- note
- Source null
- related pmid
- 28583288
- relationship
- Erratum in
- outcomes validated
- false
- pmid
- 28291640
- provenance
- batch id
- 7a1288ac8bb5f9826304
- provider
- NCBI PubMed ESummary
- record sha256
- 3d4287f2796418c4f66bb7f07174b2c7ebd07e9bfced14e9aaaf74a849df9a23
- response sha256
- 0e879bec8c19d1cfda5629dca8745b04155d18cf54361825d4c070aebad2984d
- retrieved at
- 2026-09-09T23:47:23.138359+00:00
- publication date
- display
- 2017 Apr
- precision
- month
- year
- 2017
- publication types
- Clinical Trial
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Pegylated interferon alfa-2a in patients with essential thrombocythaemia or polycythaemia vera: a post-hoc, median 83 month follow-up of an open-label, phase 2 trial.
Preserved source evidence · Not medical advice